Comparative Investigation of Aegle marmelos Linn Seeds and Barks for Anti-cancer Activity Against Cell Lines: In-vitro Evidence
This study explores the comparative anti-cancer potential of Aegle marmelos Linn. (Bael) seed and
bark extracts against MCF-7 human breast cancer cell lines using in-vitro assays (MTT and SRB).
Extracts were prepared using ethanol and water and evaluated for phytochemical constituents,
physical parameters, and cytotoxic efficacy. Phytochemical analysis confirmed the presence of
alkaloids, tannins, saponins, and flavonoids. The ethanolic bark extract demonstrated a significant
dose-dependent cytotoxic effect, achieving an IC₅₀ of 82.17 µg/ml in the MTT assay and 44.03 µg/ml
in the SRB assay. In contrast, the aqueous seed extract showed comparatively lower activity. These
findings suggest that the ethanolic bark extract of Aegle marmelos exhibits notable anti-cancer
activity and has the potential to be developed into a plant-based therapeutic agent for breast cancer
treatment.
bark extracts against MCF-7 human breast cancer cell lines using in-vitro assays (MTT and SRB).
Extracts were prepared using ethanol and water and evaluated for phytochemical constituents,
physical parameters, and cytotoxic efficacy. Phytochemical analysis confirmed the presence of
alkaloids, tannins, saponins, and flavonoids. The ethanolic bark extract demonstrated a significant
dose-dependent cytotoxic effect, achieving an IC₅₀ of 82.17 µg/ml in the MTT assay and 44.03 µg/ml
in the SRB assay. In contrast, the aqueous seed extract showed comparatively lower activity. These
findings suggest that the ethanolic bark extract of Aegle marmelos exhibits notable anti-cancer
activity and has the potential to be developed into a plant-based therapeutic agent for breast cancer
treatment.